That's not relevant in the line of discussion..MCL remuneration of performance rights/shares has no bearing operationally for the company. You've just completely gone left field with what you've now said people should read imo.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025